{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:09:40Z","timestamp":1780394980078,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Shanghai Science and Technology Innovation Action Plan\uff0cexperimental animal research\u00a0project","award":["23141901900"],"award-info":[{"award-number":["23141901900"]}]},{"name":"the Shanghai Pujiang Program","award":["23PJD073"],"award-info":[{"award-number":["23PJD073"]}]},{"name":"Basic Research Project of the Sixth People's Hospital of Shanghai","award":["ynms202306"],"award-info":[{"award-number":["ynms202306"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"DOI":"10.1007\/s10875-026-02009-x","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:03:37Z","timestamp":1776740617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adult Onset of MSMD Caused by IL-12R\u03b21 Variants: Report of a Young Woman with NTM Infection Lacking Bacille Calmette\u2013Gu\u00e9rin (BCG)-induced Diseases"],"prefix":"10.1007","volume":"46","author":[{"given":"Jinmei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"11","key":"2009_CR1","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S1473-3099(09)70255-5","volume":"9","author":"E van de Vosse","year":"2009","unstructured":"van de Vosse E, van Dissel JT, Ottenhoff TH. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis. 2009;9(11):688\u201398.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"2009_CR2","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.cmi.2022.03.004","volume":"28","author":"K Noma","year":"2022","unstructured":"Noma K, et al. Mendelian susceptibility to mycobacterial diseases: state of the art. Clin Microbiol Infect. 2022;28(11):1429\u201334.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"2009_CR3","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1172\/JCI135460","volume":"130","author":"G Kerner","year":"2020","unstructured":"Kerner G, et al. Inherited human IFN-\u03b3 deficiency underlies mycobacterial disease. J Clin Invest. 2020;130(6):3158\u201371.","journal-title":"J Clin Invest"},{"issue":"7","key":"2009_CR4","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.cell.2020.10.046","volume":"183","author":"R Yang","year":"2020","unstructured":"Yang R, et al. Human T-bet governs innate and innate-like adaptive IFN-\u03b3 immunity against mycobacteria. Cell. 2020;183(7):1826-1847.e31.","journal-title":"Cell"},{"key":"2009_CR5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102804118","author":"T Le Voyer","year":"2021","unstructured":"Le Voyer T, et al. Inherited deficiency of stress granule ZNFX1 in patients with monocytosis and mycobacterial disease. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2102804118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2009_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cell.2022.12.038","volume":"186","author":"J Rosain","year":"2023","unstructured":"Rosain J, et al. Human IRF1 governs macrophagic IFN-\u03b3 immunity to mycobacteria. Cell. 2023;186(3):621-645.e33.","journal-title":"Cell"},{"issue":"23","key":"2009_CR7","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1016\/j.cell.2023.09.024","volume":"186","author":"J Bohlen","year":"2023","unstructured":"Bohlen J, et al. Human MCTS1-dependent translation of JAK2 is essential for IFN-\u03b3 immunity to mycobacteria. Cell. 2023;186(23):5114-5134.e27.","journal-title":"Cell"},{"issue":"3","key":"2009_CR8","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jaci.2024.12.1078","volume":"155","author":"S Boisson-Dupuis","year":"2025","unstructured":"Boisson-Dupuis S, et al. The monogenic landscape of human infectious diseases. J Allergy Clin Immunol. 2025;155(3):768\u201383.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2009_CR9","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jaci.2024.01.021","volume":"153","author":"A Khavandegar","year":"2024","unstructured":"Khavandegar A, et al. Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): a systematic review. J Allergy Clin Immunol. 2024;153(5):1432\u201344.","journal-title":"J Allergy Clin Immunol"},{"key":"2009_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","volume":"20","author":"JL Casanova","year":"2002","unstructured":"Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581\u2013620.","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"2009_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","volume":"26","author":"J Bustamante","year":"2014","unstructured":"Bustamante J. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol. 2014;26(6):454\u201370.","journal-title":"Semin Immunol"},{"issue":"6","key":"2009_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","volume":"26","author":"J Bustamante","year":"2014","unstructured":"Bustamante J, et al. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity. Semin Immunol. 2014;26(6):454\u201370.","journal-title":"Semin Immunol"},{"issue":"5","key":"2009_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13(5):715\u201325.","journal-title":"Immunity"},{"issue":"24","key":"2009_CR14","doi-asserted-by":"publisher","first-page":"14002","DOI":"10.1073\/pnas.93.24.14002","volume":"93","author":"DH Presky","year":"1996","unstructured":"Presky DH, et al. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A. 1996;93(24):14002\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2009_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.170.3.827","volume":"170","author":"M Kobayashi","year":"1989","unstructured":"Kobayashi M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med. 1989;170(3):827\u201345.","journal-title":"J Exp Med"},{"issue":"11","key":"2009_CR16","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","volume":"168","author":"C Parham","year":"2002","unstructured":"Parham C, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol. 2002;168(11):5699\u2013708.","journal-title":"J Immunol"},{"issue":"6\u20137","key":"2009_CR17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00439-020-02120-y","volume":"139","author":"J Bustamante","year":"2020","unstructured":"Bustamante J. Mendelian susceptibility to mycobacterial disease: recent discoveries. Hum Genet. 2020;139(6\u20137):993\u20131000.","journal-title":"Hum Genet"},{"issue":"6","key":"2009_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/MD.0b013e3181fdd832","volume":"89","author":"L de Beaucoudrey","year":"2010","unstructured":"de Beaucoudrey L, et al. Revisiting human IL-12R\u03b21 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore). 2010;89(6):381\u2013402.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"2009_CR19","first-page":"977","volume":"11","author":"LO Larsson","year":"2017","unstructured":"Larsson LO, et al. Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives. Expert Rev Respir Med. 2017;11(12):977\u201389.","journal-title":"Expert Rev Respir Med"},{"key":"2009_CR20","doi-asserted-by":"publisher","first-page":"631298","DOI":"10.3389\/fimmu.2021.631298","volume":"12","author":"PD Taur","year":"2021","unstructured":"Taur PD, et al. Clinical and molecular findings in mendelian susceptibility to mycobacterial diseases: experience from India. Front Immunol. 2021;12:631298.","journal-title":"Front Immunol"},{"key":"2009_CR21","doi-asserted-by":"publisher","first-page":"926781","DOI":"10.3389\/fimmu.2022.926781","volume":"13","author":"L Xia","year":"2022","unstructured":"Xia L, et al. An updated review on MSMD research globally and a literature review on the molecular findings, clinical manifestations, and treatment approaches in China. Front Immunol. 2022;13:926781.","journal-title":"Front Immunol"},{"issue":"6","key":"2009_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jmii.2012.08.017","volume":"45","author":"LH Wang","year":"2012","unstructured":"Wang LH, et al. Impact of molecular diagnosis on treating Mendelian susceptibility to mycobacterial diseases. J Microbiol Immunol Infect. 2012;45(6):411\u20137.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"2009_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12941-022-00500-y","volume":"21","author":"SA Mahdaviani","year":"2022","unstructured":"Mahdaviani SA, et al. Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series. Ann Clin Microbiol Antimicrob. 2022;21(1):8.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"5","key":"2009_CR24","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.imbio.2012.08.281","volume":"218","author":"WI Lee","year":"2013","unstructured":"Lee WI, et al. Patients with inhibitory and neutralizing auto-antibodies to interferon-\u03b3 resemble the sporadic adult-onset phenotype of Mendelian susceptibility to mycobacterial disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases. Immunobiology. 2013;218(5):762\u201371.","journal-title":"Immunobiology"},{"issue":"12","key":"2009_CR25","doi-asserted-by":"publisher","first-page":"e22632","DOI":"10.1016\/j.heliyon.2023.e22632","volume":"9","author":"Y Yang","year":"2023","unstructured":"Yang Y, Xia L, Lu S. Adult-onset mendelian susceptibility to mycobacterial diseases: a case report and systematic literature review. Heliyon. 2023;9(12):e22632.","journal-title":"Heliyon"},{"issue":"4","key":"2009_CR26","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s10875-022-01419-x","volume":"43","author":"A Errami","year":"2023","unstructured":"Errami A, et al. Mendelian susceptibility to mycobacterial disease (MSMD): clinical, immunological, and genetic features of 22 patients from 15 Moroccan kindreds. J Clin Immunol. 2023;43(4):728\u201340.","journal-title":"J Clin Immunol"},{"key":"2009_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau6759","author":"R Mart\u00ednez-Barricarte","year":"2018","unstructured":"Mart\u00ednez-Barricarte R, et al. Human IFN-\u03b3 immunity to mycobacteria is governed by both IL-12 and IL-23. Sci Immunol. 2018. https:\/\/doi.org\/10.1126\/sciimmunol.aau6759.","journal-title":"Sci Immunol"},{"issue":"4","key":"2009_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1164\/rccm.200502-278OC","volume":"172","author":"K Dheda","year":"2005","unstructured":"Dheda K, et al. In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis. Am J Respir Crit Care Med. 2005;172(4):501\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2009_CR29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10875-011-9566-y","volume":"31","author":"R Hussain","year":"2011","unstructured":"Hussain R, et al. Endogenously activated interleukin-4 differentiates disease progressors and non-progressors in tuberculosis susceptible families: a 2-year biomarkers follow-up study. J Clin Immunol. 2011;31(5):913\u201323.","journal-title":"J Clin Immunol"},{"issue":"80","key":"2009_CR30","doi-asserted-by":"publisher","first-page":"eabq5204","DOI":"10.1126\/sciimmunol.abq5204","volume":"8","author":"Q Philippot","year":"2023","unstructured":"Philippot Q, et al. Human IL-23 is essential for IFN-\u03b3-dependent immunity to mycobacteria. Sci Immunol. 2023;8(80):eabq5204.","journal-title":"Sci Immunol"},{"issue":"7","key":"2009_CR31","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1084\/jem.20080321","volume":"205","author":"L de Beaucoudrey","year":"2008","unstructured":"de Beaucoudrey L, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med. 2008;205(7):1543\u201350.","journal-title":"J Exp Med"},{"issue":"3","key":"2009_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-024-01661-5","volume":"44","author":"J Rosain","year":"2024","unstructured":"Rosain J, et al. Recombinant IFN-\u03b31b treatment in a patient with inherited IFN-\u03b3 deficiency. J Clin Immunol. 2024;44(3):62.","journal-title":"J Clin Immunol"},{"issue":"6","key":"2009_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.smim.2006.07.010","volume":"18","author":"O Filipe-Santos","year":"2006","unstructured":"Filipe-Santos O, et al. Inborn errors of IL-12\/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol. 2006;18(6):347\u201361.","journal-title":"Semin Immunol"},{"issue":"3","key":"2009_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/ijmr.IJMR_902_20","volume":"152","author":"SK Sharma","year":"2020","unstructured":"Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res. 2020;152(3):185\u2013226.","journal-title":"Indian J Med Res"},{"issue":"5","key":"2009_CR35","first-page":"326","volume":"41","author":"B Gemici Karaaslan","year":"2024","unstructured":"Gemici Karaaslan B, et al. Interferon gamma in sickness predisposing to mycobacterial infectious diseases. Balkan Med J. 2024;41(5):326\u201332.","journal-title":"Balkan Med J"},{"key":"2009_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13030203","author":"A Dalvi","year":"2024","unstructured":"Dalvi A, et al. Diagnosis and management of infections in patients with Mendelian susceptibility to mycobacterial disease. Pathogens. 2024. https:\/\/doi.org\/10.3390\/pathogens13030203.","journal-title":"Pathogens"},{"issue":"1","key":"2009_CR37","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1371\/journal.pmed.0050026","volume":"5","author":"M Rottman","year":"2008","unstructured":"Rottman M, et al. IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts. PLoS Med. 2008;5(1):e26.","journal-title":"PLoS Med"},{"issue":"10","key":"2009_CR38","doi-asserted-by":"publisher","first-page":"881 e1","DOI":"10.1016\/j.jtct.2021.07.013","volume":"27","author":"HF Nazir","year":"2021","unstructured":"Nazir HF, et al. Hematopoietic stem cell transplantation for patients with autosomal recessive complete INF-lambda receptor 2 deficiency: experience in Oman. Transplant Cell Ther. 2021;27(10):881 e1-881 e5.","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"2009_CR39","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10875-017-0430-6","volume":"37","author":"S Naviglio","year":"2017","unstructured":"Naviglio S, et al. Long-term survival after hematopoietic stem cell transplantation for complete STAT1 deficiency. J Clin Immunol. 2017;37(7):701\u20136.","journal-title":"J Clin Immunol"},{"issue":"11","key":"2009_CR40","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/pbc.25625","volume":"62","author":"P Olbrich","year":"2015","unstructured":"Olbrich P, et al. Diagnostic and therapeutic challenges in a child with complete interferon-\u03b3 receptor 1 deficiency. Pediatr Blood Cancer. 2015;62(11):2036\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2009_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-021-00452-6","volume":"22","author":"A van Coller","year":"2021","unstructured":"van Coller A, et al. Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa. BMC Immunol. 2021;22(1):62.","journal-title":"BMC Immunol"},{"issue":"6","key":"2009_CR42","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s10875-019-00672-x","volume":"39","author":"W Ying","year":"2019","unstructured":"Ying W, et al. Current status of the management of Mendelian Susceptibility to Mycobacterial Disease in mainland China. J Clin Immunol. 2019;39(6):600\u201310.","journal-title":"J Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-026-02009-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02009-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02009-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:16:57Z","timestamp":1780391817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-026-02009-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2009"],"URL":"https:\/\/doi.org\/10.1007\/s10875-026-02009-x","relation":{},"ISSN":["1573-2592"],"issn-type":[{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the individual for the publication of any potentially identifiable images or data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"60"}}